Tumor-derived cytokines impair myogenesis and alter the skeletal muscle immune microenvironment KA Hogan, DS Cho, PC Arneson, A Samani, P Palines, Y Yang, JD Doles Cytokine 107, 9-17, 2018 | 45 | 2018 |
The wasting‐associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration PC Arneson‐Wissink, KA Hogan, AM Ducharme, A Samani, A Jatoi, ... JCSM rapid communications 3 (2), 56-69, 2020 | 14 | 2020 |
Impaired muscle regeneration in cancer-associated cachexia PC Arneson, JD Doles Trends in cancer 5 (10), 579-582, 2019 | 14 | 2019 |
A novel transplantable model of lung cancer-associated tissue loss and disrupted muscle regeneration PC Arneson-Wissink, AM Ducharme, JD Doles Skeletal Muscle 10, 1-13, 2020 | 11 | 2020 |
Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer A Dasgupta, PC Arneson-Wissink, RE Schmitt, DS Cho, AM Ducharme, ... JCI insight 7 (2), 2022 | 8 | 2022 |
Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis RE Schmitt, A Dasgupta, PC Arneson‐Wissink, S Datta, AM Ducharme, ... Journal of Cachexia, Sarcopenia and Muscle 14 (3), 1424-1440, 2023 | 6 | 2023 |
A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer A Dasgupta, DF Gibbard, RE Schmitt, PC Arneson-Wissink, ... Proceedings of the National Academy of Sciences 120 (34), e2215095120, 2023 | 5 | 2023 |
Disrupted NOS2 metabolism drives myoblast response to wasting-associated cytokines PC Arneson-Wissink, JD Doles Experimental cell research 407 (1), 112779, 2021 | 4 | 2021 |
Hepatic signal transducer and activator of transcription‐3 signalling drives early‐stage pancreatic cancer cachexia via suppressed ketogenesis PC Arneson‐Wissink, H Mendez, K Pelz, J Dickie, AQ Bartlett, BL Worley, ... Journal of Cachexia, Sarcopenia and Muscle 15 (3), 975-988, 2024 | 1 | 2024 |
Quantification of Muscle Stem Cell Differentiation Using Live-Cell Imaging and Eccentricity Measures PC Arneson-Wissink, JD Doles Stem Cell Assays: Methods and Protocols, 455-471, 2022 | 1 | 2022 |
With Appreciation M Alexander, M Bahls, R Bohannon, J Brault, LK Chen, P Costelli, L Dai, ... Journal of Cachexia, Sarcopenia and Muscle 14, 2995-2997, 2023 | | 2023 |
IL-6/STAT3 signaling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis PC Arneson-Wissink, H Mendez, K Pelz, J Dickie, AQ Bartlett, BL Worley, ... bioRxiv, 2022.10. 18.512778, 2022 | | 2022 |
Identification of perp as a tumor promoter in pancreatic cancer via the utilization of an aged model of cancer cachexia A Dasgupta, PC Arneson-Wissink, RE Schmitt, DS Cho, AM Ducharme, ... Cancer Research 82 (12_Supplement), 3995-3995, 2022 | | 2022 |
Tumor-derived IL-6 impairs hepatic adaptive response to undernutrition in pancreatic cancer cachexia PC Arneson-Wissink, H Mendez, K Pelz, J Dickie, X Zhu, B Olson, ... Cancer Research 82 (12_Supplement), 2175-2175, 2022 | | 2022 |
Anti-cachectic regulator analysis reveals novel Perp-dependent anti-tumorigenic properties of 3-methyladenine in pancreatic cancer A Dasgupta, PC Arneson-Wissink, RE Schmitt, D Seong, AM Cho, ... JCI Insight, 2021 | | 2021 |
Intrinsic and Extrinsic Changes Contribute to Impaired Muscle Stem Cell Function and Muscle Regeneration in Cancer Cachexia PC Arneson-Wissink College of Medicine-Mayo Clinic, 2021 | | 2021 |
A novel transplantable model of lung cancer associated tissue loss and disrupted muscle regeneration PC Arneson, AM Ducharme, JD Doles bioRxiv, 852442, 2019 | | 2019 |